Filing Details
- Accession Number:
- 0001181431-12-012617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-28 12:00:00
- Reporting Period:
- 2012-02-24
- Filing Date:
- 2012-02-28
- Accepted Time:
- 2012-02-28 17:01:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
893949 | Mednax Inc. | MD | Services-Hospitals (8060) | 650271219 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1443082 | A. David Clark | 1301 Concord Terrace Sunrise FL 33323-2825 | Coo / Pediatrix Division | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-24 | 9,700 | $55.43 | 26,935 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-24 | 9,700 | $75.45 | 17,235 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-27 | 4,100 | $55.43 | 21,335 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-27 | 4,100 | $75.50 | 17,235 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-02-24 | 9,700 | $55.43 | 9,700 | $55.43 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-02-27 | 4,100 | $55.43 | 4,100 | $55.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,100 | 2011-06-01 | 2018-06-02 | No | 4 | M | Direct |
0 | 2011-06-01 | 2018-06-02 | No | 4 | M | Direct |
Footnotes
- Sales of shares were made pursuant to Reporting Person's 10b5-1 trading plan.
- Sales of shares were executed in sixteen (16) separate transactions with prices ranging from $75.43 to $75.59 for a weighted average sales price of $75.4539.
- Sales of shares were executed in nineteen (19) separate transactions with prices ranging from $75.43 to $75.63 for a weighted average sales price of $75.5029.